← Open Payments lookup

IZABELLA OSTOLSKI: Open Payments

NPI 1598989691 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,197 in 52 payments from 18 companies in 2025. Trend: 2023 $286 · 2024 $1,101 · 2025 $1,197

Food & beverage: $1,197
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$230
Vanda Pharmaceuticals Inc.8$178
ABBVIE INC.8$149
Takeda Pharmaceuticals U.S.A., Inc.4$91
Alkermes, Inc.3$80
Bausch Health US, LLC4$78
Almatica Pharma LLC3$70
Tris Pharma Inc2$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Neurocrine BioSciences, Inc.1$39

Products named: REXULTI, FANAPT, VRAYLAR, TRINTELLIX, ARISTADA, APLENZIN, LOREEV XR, Dyanavel XR.

Industry payments across NV — which companies pay providers there.